Register entry
Sichuan Xieli Pharmaceutical Co Ltd
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Sichuan Xieli Pharmaceutical Co Ltd | PengzhouChina | Active ingredient (API) manufacture, Finished drug manufacture | 3007432586 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Anastrozole | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cabazitaxel | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | DASATINIB MONOLAURYL SULFATE | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Erlotinib Hydrochloride | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Irinotecan Hydrochloride | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | URSODIOL | POWDER, FOR SUSPENSION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.